The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

VMPL Hyderabad Telangana [India] January 13 CARE Hospitals one of India leading healthcare providers successfully treated a ...

We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Middle East and Asia Injectable Drugs market 2025 To achieve a therapeutic effect in humans and animals, drug delivery is the method of delivering a Pharmaceutical compound. Mr. Shah Coherent Market ...

Stryker (NYSE: SYK), a global leader in medical technologies, has announced its definitive agreement to acquire Inari Medical ...

Kauvery Hospital Vadapalani is pleased to announce a series of remarkable achievements in its management of ST-Elevation ...

Stryker ( (SYK) ) has provided an announcement.Stay Ahead of the Market:Discover outperforming stocks and invest smarter with Top Smart Score ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock ...